DOXORUBICIN AND CISPLATIN FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：0
|
作者：
SANDLER, S
BONOMI, P
TAYLOR, B
SHOWEL, J
SLAYTON, R
LERNER, H
机构：
[1] RUSH MED COLL,DEPT INTERNAL MED,CHICAGO,IL 60612
[2] RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612
[3] PENN HOSP,PHILADELPHIA,PA 19107
来源：
CANCER TREATMENT REPORTS | 1984年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1163 / 1165
页数：3
相关论文
共 50 条
  • [41] CISPLATIN AS 2ND LINE CHEMOTHERAPY IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK REGION
    KELDSEN, N
    [J]. ACTA ONCOLOGICA, 1987, 26 (05) : 357 - 359
  • [42] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [43] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [44] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
    Mirabile, Aurora
    Miceli, Rosalba
    Calderone, Rosa Gioia
    Locati, Laura
    Bossi, Paolo
    Bergamini, Cristiana
    Granata, Roberta
    Perrone, Federica
    Mariani, Luigi
    Licitra, Lisa
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
  • [45] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [46] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [47] Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma
    Ducoulombier, Agnes
    Guigay, Joel
    Etienne-Grimaldi, Marie-Christine
    Saada-Bouzid, Esma
    [J]. CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 166 - 177
  • [48] Prognostic Factors in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Rosko, A.
    Heft-Neal, M. E.
    Shuman, A.
    Brenner, J. C.
    Worden, F.
    Spector, M. E.
    Swiecicki, P. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1177 - 1177
  • [49] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [50] Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck
    Recchia, Francesco
    Candeloro, Giampiero
    Di Staso, Mario
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Tombolini, Vincenzo
    Rea, Silvio
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (04) : 413 - 419
12345